SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–InterVenn Biosciences today announced additions to the Company’s executive team in the month of April. Stephana Patton, Ph.D., J.D. joins InterVenn as Chief Legal Officer (CLO).…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–InterVenn Biosciences today announced that Padmanee Sharma, MD, PhD, has joined the Company’s Board of Advisors, effective March 9, 2021. Dr. Sharma joins the InterVenn Board…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–InterVenn Biosciences, the leader in glycoproteomics, announced today that it has developed a glycoproteomics-based signature that accurately predicts which malignant melanoma patients will respond to checkpoint…